MUC1 and neoplasm: During chronic inflammation and carcinogenesis, M2 macrophages induce the expression of ST6GALNAC1, thereby promoting abnormal glycosylation of MUC1, leading to the formation of tumor-associated sialyl-Tn (sTn) O-glycans, exacerbating disease progression [42].